BUZZ-Disc Medicine falls after flagging 'material weakness'

Reuters

Jan 11

BUZZ-<a href="https://laohu8.com/S/IRON">Disc Medicine</a> falls after flagging 'material weakness'

** Drug developer Disc Medicine's IRON.O shares fall ~5% to $59.46

** Company says in filing it expects to report material weakness in its internal control over financial reporting for year ending Dec. 31, 2024

** Disc Medicine adds issue due to ineffective Information Technology General Controls (ITGC) - policies aimed at keeping the company's IT systems secure and working properly - over some key financial IT systems

** Company says no misstatements have been identified in its financial statements so far

** Disc Medicine says its auditor has not completed the audit of its internal controls and cannot provide an opinion yet

** All 11 brokerages rate the stock "buy" or higher; median PT $90 - LSEG

** Company's shares gained 6.1% in 2024

(Reporting by Kamal Choudhury in Bengaluru)

((Kamal.Choudhury@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2502996138"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2502996138\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2502996138?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-01-11 00:16","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2502996138","market":"us","top_or_hot":-1,"title":"BUZZ-Disc Medicine falls after flagging 'material weakness'","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-<a href=\"https://laohu8.com/S/IRON\">Disc Medicine</a> falls after flagging 'material weakness'</title></head><body><p>** Drug developer Disc Medicine's <span>IRON.O</span> shares fall ~5% to $59.46</p><p>** Company says in filing it expects to report material weakness in its internal control over financial reporting for year ending Dec. 31, 2024</p><p>** Disc Medicine adds issue due to ineffective Information Technology General Controls (ITGC) - policies aimed at keeping the company's IT systems secure and working properly - over some key financial IT systems</p><p>** Company says no misstatements have been identified in its financial statements so far</p><p>** Disc Medicine says its auditor has not completed the audit of its internal controls and cannot provide an opinion yet</p><p>** All 11 brokerages rate the stock \"buy\" or higher; median PT $90 - LSEG</p><p>** Company's shares gained 6.1% in 2024</p><p>(Reporting by Kamal Choudhury in Bengaluru)</p><p>((Kamal.Choudhury@thomsonreuters.com))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-Disc Medicine falls after flagging 'material weakness'</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-Disc Medicine falls after flagging 'material weakness'\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-01-11 00:16</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-<a href=\"https://laohu8.com/S/IRON\">Disc Medicine</a> falls after flagging 'material weakness'</title></head><body><p>** Drug developer Disc Medicine's <span>IRON.O</span> shares fall ~5% to $59.46</p><p>** Company says in filing it expects to report material weakness in its internal control over financial reporting for year ending Dec. 31, 2024</p><p>** Disc Medicine adds issue due to ineffective Information Technology General Controls (ITGC) - policies aimed at keeping the company's IT systems secure and working properly - over some key financial IT systems</p><p>** Company says no misstatements have been identified in its financial statements so far</p><p>** Disc Medicine says its auditor has not completed the audit of its internal controls and cannot provide an opinion yet</p><p>** All 11 brokerages rate the stock \"buy\" or higher; median PT $90 - LSEG</p><p>** Company's shares gained 6.1% in 2024</p><p>(Reporting by Kamal Choudhury in Bengaluru)</p><p>((Kamal.Choudhury@thomsonreuters.com))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250110:nL4N3O61A4:1","article_id":"2502996138","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2502996138","pubTimestamp":1736525782,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BUZZ-Disc Medicine falls after flagging 'material weakness'** Drug developer Disc Medicine's IRON.O shares fall ~5% to $59.46** Company says in filing it expects to report material weakness in its internal control over financial reporting for year ending Dec. 31, 2024** Disc Medicine adds issue due to ineffective Information Technology General Controls  - policies aimed at keeping the company's IT systems secure and working properly - over some key financial IT systems** Company says no misstatements have been identified in its financial statements so far** Disc Medicine says its auditor has not completed the audit of its internal controls and cannot provide an opinion yet** All 11 brokerages rate the stock \"buy\" or higher; median PT $90 - LSEG** Company's shares gained 6.1% in 2024","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","IRON":"Disc Medicine"},"translate_title":"BUZZ-Disc Medicine在表示“实质性疲软”后下跌","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IRON":0.9},"content_text":"BUZZ-Disc Medicine falls after flagging 'material weakness'** Drug developer Disc Medicine's IRON.O shares fall ~5% to $59.46** Company says in filing it expects to report material weakness in its internal control over financial reporting for year ending Dec. 31, 2024** Disc Medicine adds issue due to ineffective Information Technology General Controls (ITGC) - policies aimed at keeping the company's IT systems secure and working properly - over some key financial IT systems** Company says no misstatements have been identified in its financial statements so far** Disc Medicine says its auditor has not completed the audit of its internal controls and cannot provide an opinion yet** All 11 brokerages rate the stock \"buy\" or higher; median PT $90 - LSEG** Company's shares gained 6.1% in 2024(Reporting by Kamal Choudhury in Bengaluru)((Kamal.Choudhury@thomsonreuters.com))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}